A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

• Alessandra Tedeschi,
• Richard Greil,
• Fatih Demirkan,
• Tadeusz Robak,
• Carol Moreno,
• Paul M. Barr,
• Bertrand Anz,
• David Simpson,
• Gianluca Gaidano,
• Osnat Bairey,
• Don Stevens,
• Devinder Gill,
• Ian W. Flinn,
• Thomas J. Kipps,
• Jan A. Burger,
• Jennifer Lin,
• Thomas Webb,
• Viktor Fedorov,
• Lori Styles,
• John G. Gribben

Affiliations

Alessandra Tedeschi

ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Richard Greil

Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria

Fatih Demirkan

Dokuz Eylul University, Izmir, Turkey

Tadeusz Robak

Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

Carol Moreno

Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain

Paul M. Barr

Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA

Bertrand Anz

Tennessee Oncology, Chattanooga, TN, USA

David Simpson

North Shore Hospital, Auckland, New Zealand

Gianluca Gaidano

Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Osnat Bairey

Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Don Stevens

Norton Cancer Institute, Louisville, KY, USA

Devinder Gill

Princess Alexandra Hospital, Brisbane, Australia

Ian W. Flinn

Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA

Thomas J. Kipps

University of California, San Diego, Moores Cancer Center, La Jolla, CA, USA

Jan A. Burger

The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jennifer Lin

Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA

Thomas Webb

Janssen Ltd, High Wycombe, UK

Viktor Fedorov

Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA

Lori Styles

Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA

John G. Gribben

Barts Cancer Institute, Queen Mary University of London, London, UK